Gain detailed insights into the trading activity of Congress members for Macerich on our government trades page. Stay updated on how elected officials are investing in MAC.

Macerich - Government Trades

Macerich

The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.

Skyscrapers,Cityscape,Downtown,View,,Nashville,Skyline,Buildings.,Beautiful,Real,Estate.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Real Estate Stocks That May Plunge This Month

xr:d:DAF1o5RCqe8:2,j:6153453808996259115,t:23113011

Upgrades

Analyst Ratings

PSTG

SHBI

TRMB

This Pure Storage Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top 3 Real Estate Stocks That May Plunge This Quarter

florida real estate

BEKE

UNIT

Top 4 Real Estate Stocks You May Want To Dump In September

xr:d:DAFgoMtGiio:2,j:3076721974,t:23042008

Long Ideas

Insider Trades

XPEL

Insiders Buying PPG Industries And 2 Other Stocks

Image21

Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying

mall holiday shopping shutter

Equities

Large Cap

Downgrades

Price Target

PSCF

VIOV

Macerich Co (NYSE: MAC) downgraded &amp; reduced price target by Piper Sandler. Reported Q1 sales of $208.783M &amp; FFO of $0.33. New CEO appointed &amp; withdrew FY24 guidance. Analyst skeptical of turnaround strategy, lowers FFO estimates for FY24 &amp; FY25.

Analyst Doubts Macerich&#39;s New CEO Strategy, Can They Turn Things Around?

Seattle,,Washington - usa,-,January,22,,2018:,Amazon,Go,Store,Sign

AMZN

CECO

PYPL

SBUX

SIRI

SWKS

ZBRA

Amazon To Rally Over 37%? Here Are 10 Top Analyst Forecasts For Wednesday

Image45

Intraday Update

Movers

ADXN

AGBA

AKLI

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CETX

CHGG

COUR

CSLR

CYCC

DARE

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

LICN

MIND

MRIN

MSTR

MULN

NIVF

NRXP

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&amp;E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

money homes shutter

Macro Economic Events

Macro Notification

Mid Cap

REIT

Sector ETFs

Small Cap

Econ #s

Economics

ETFs

Real Estate

NXRT

OPEN

RDFN

SBAC

Home prices defied high mortgage costs and surpassed expectations with a 1.2% month-over-month growth, the largest increase since Apr 2022.

US Home Prices Rocket In February For Strongest One-Month Increase In 2 Years: Real Estate Stocks React

Macerich Co

MORINGA ACQUISITION CORP USD CL A ORD SHS

MORINGA ACQUISITION CORP USD UNITS CONSISTING ONE CL A ORD SH & ONE HALF WT TO PUR CL

MORINGA ACQUISITION CORP USD WTS TO PUR CL A ORD SHS

Mace Security International Inc

Melar Acquisition Corp. I - Class A Ordinary Shares

Melar Acquisition Corp I

Merrimack Pharmaceuticals Inc Com (New)

THEMAC RESOURCES GRP LTD by Themac Resources Group Ltd.

Themac Resources Group Ltd

Machten Inc

<p>Scotiabank  analyst Nicholas Yulico   upgrades Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) from Sector Underperform to Sector Perform and announces $22 price target.</p>


Scotiabank Upgrades Macerich to Sector Perform, Announces $22 Price Target

<p>Deutsche Bank  analyst Omotayo Okusanya   initiates coverage on Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Hold rating and announces Price Target of $22.</p>


Initiation

Deutsche Bank Initiates Coverage On Macerich with Hold Rating, Announces Price Target of $22

<p>As of Dec. 16, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>CBL &amp; Associates Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBL#NYSE">CBL</a>)</strong></h3>
<ul>
<li>On Nov. 11, CBL &amp; Associates posted an increase in quarterly EPS. &#8220;The overall environment for the shopping center industry remains positive,&#8221; said CBL&#8217;s chief executive officer, Stephen D. Lebovitz. The company's shares gained around 14% over the past month and has a <a href="https://www.benzinga.com/quote/CBL">52-week high of $32.20</a>.</li>
<li><strong>RSI Value:</strong> 70.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>CBL Price Action:</strong> Shares of CBL gained 0.3% to close at $31.44 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Macerich Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>)</strong></h3>
<ul>
<li>On Dec. 11, Piper Sandler analyst Alexander Goldfarb maintained Macerich with an Underweight and raised the price target from $14 to $17. The company's stock gained around 11% over the past month and <a href="https://www.benzinga.com/quote/MAC">has a 52-week high</a> of $22.27.</li>
<li><strong>RSI Value:</strong> 70.59</li>
<li><strong>MAC Price Action:</strong> Shares of Macerich closed at $21.50 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Sunstone Hotel Investors Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>)</h3>
<ul>
<li>On Dec. 9, Wells Fargo analyst Dori Kesten maintained Sunstone Hotel Investors with an Equal-Weight and raised the price target from $11 to $13. The company's stock gained around 21% over the past month and has a <a href="https://www.benzinga.com/quote/SHO">52-week high</a> of $12.35.</li>
<li><strong>RSI Value:</strong> 77.04</li>
<li><strong>SHO Price Action:</strong> Shares of Sunstone Hotel Investors closed at $12.21 on Friday.</li>
</ul>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></strong></li>
</ul>


<p>Piper Sandler  analyst Alexander Goldfarb   maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Underweight and raises the price target from $14 to $17.</p>


Piper Sandler Maintains Underweight on Macerich, Raises Price Target to $17

<p>Across the recent three months, 4 analysts have shared their insights on Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Macerich, presenting an average target of $19.65, a high estimate of $23.00, and a low estimate of $14.60. Surpassing the previous average price target of $16.00, the current average has increased by 22.81%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1733320886_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of Macerich among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$23.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jeffrey Spector</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Caitlin Burrows</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$14.60</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Macerich. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Macerich compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Macerich's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Macerich's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MAC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Macerich analyst ratings.</strong></a></p>
<h2>All You Need to Know About Macerich</h2>
<p>The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.</p>
<h3>Financial Insights: Macerich</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Macerich's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>0.95%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Macerich's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-49.24%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Macerich's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-4.32%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-1.41%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Macerich's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.76</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Cracking The Code: Understanding Analyst Reviews For Macerich

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Mizuho analyst Haendel St. Juste upgraded the rating for <strong>The Macerich Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) from Underperform to Neutral and raised the price target from $14 to $22. Macerich shares closed at $21.10 on Tuesday. <a href="https://www.benzinga.com/quote/MAC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst James Fish upgraded <strong>Pure Storage, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) from Neutral to Overweight and increased the price target from $56 to $76. Pure Storage shares closed at $53.54 on Tuesday. <a href="https://www.benzinga.com/quote/PSTG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan analyst Tami Zakaria upgraded the rating for <strong>Trimble Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>) from Neutral to Overweight and boosted the price target from $74 to $92. Trimble shares closed at $73.95 on Tuesday. <a href="https://www.benzinga.com/quote/TRMB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst Catherine Mealor upgraded <strong>Shore Bancshares, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHBI#NASDAQ">SHBI</a>) from Market Perform to Outperform and raised the price target from $16 to $20. Shore Bancshares shares closed at $16.59 on Tuesday. <a href="https://www.benzinga.com/quote/SHBI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc analyst Sophie Karp upgraded the rating for <strong>Pinnacle West Capital Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) from Sector Weight to Overweight and maintained the price target of $101. Pinnacle West Capital shares closed at $91.28 on Tuesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying PSTG stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04074832/image-33-1024x561.png" alt="" class="wp-image-676306" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04074832/image-33-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04074832/image-33-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04074832/image-33-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04074832/image-33.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></strong></li>
</ul>


<p>Mizuho  analyst Haendel St. Juste   upgrades Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) from Underperform to Neutral and raises the price target from $14 to $22.</p>


Mizuho Upgrades Macerich to Neutral, Raises Price Target to $22

<p>As of Dec. 2, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>Zillow Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>)</strong></h3>
<ul>
<li>On Nov. 27, Craig-Hallum analyst Jason Kreyer maintained Zillow with a Buy and raised the price target from $70 to $95. The company's stock gained around 40% over the past month and has a <a href="https://www.benzinga.com/quote/Z">52-week high of $86.88</a>.</li>
<li><strong>RSI Value:</strong> 74.94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>Z Price Action:</strong> Shares of Zillow fell 0.9% to close at $84.71 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Howard Hughes Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>)</strong></h3>
<ul>
<li>On Nov. 4, Howard Hughes reported better-than-expected third-quarter sales results and a year-over-year increase in EPS results. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/HHH">has a 52-week hig</a>h of $87.77.</li>
<li><strong>RSI Value:</strong> 71.70</li>
<li><strong>HHH Price Action:</strong> Shares of Howard Hughes Holdings fell 0.2% to close at $86.74 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Macerich Co </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>)</h3>
<ul>
<li>On Nov. 26, Macerich priced an upsized $395 million public offering of 20 million common shares at $19.75 per share. The company's stock gained around 14% over the past month and has a <a href="https://www.benzinga.com/quote/MAC">52-week high</a> of $21.71.</li>
<li><strong>RSI Value:</strong> 74.87</li>
<li><strong>MAC Price Action:</strong> Shares of Macerich gained 0.3% to close at $21.21 on Friday. </li>
</ul>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42255665/zscaler-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Zscaler Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></strong></li>
</ul>


WIIM

Macerich shares are trading higher after the company priced an upsized $395 million public offering of 20 million common shares at $19.75 per share.

<p>The Company intends to use the net proceeds of this offering, together with cash on hand, including from recent sales under the Company's "at the market" offering program, to repay the $478.0 million mortgage loan with a fixed effective interest rate of approximately 9.0% and which is secured by its Washington Square property. Pending such use, the Compa</p>


Macerich Prices Upsized $395M Public Offering Of 20M Common Shares At $19.75/Share

<p>The Company expects to grant the underwriters a 30-day option to purchase up to 2.70 million additional shares of its common stock.</p>
<p>The Company intends to use the net proceeds of this offering together with cash on hand, including from recent sales under the Company's "at the market" offering program, to repay the $478.0 million mortgage loan with a fixed effective interest rate of approximately 9.0% and which is secured by its Washington Square property.</p>


Offerings

Macerich Commences Public Offering Of 18M Shares Of Common Stock

<p>Compass Point  analyst Floris Van Dijkum   maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Buy and raises the price target from $20 to $23.</p>


Compass Point Maintains Buy on Macerich, Raises Price Target to $23

<p>Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.40 by 10 percent.  The company reported quarterly sales of $220.224 million which beat the analyst consensus estimate of $213.571 million by 3.12 percent.  This is a 0.95 percent increase over sales of $218.152 million the same period last year.</p>


Earnings

Earnings Beats

Earnings Misses

Macerich Q3 2024 FFO $0.36 Misses $0.40 Estimate, Sales $220.224M Beat $213.571M Estimate

<p>Scott Kingsmore, the current Chief Financial Officer, will transition to the role of Senior Advisor effective November 16, 2024 and remain with the Company through December 31, 2024 to assist in the transition.</p>


Management

Macerich Names Daniel Swanstrom As CFO, Effective November 16, 2024

<p>Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) will release its quarterly earnings report on Wednesday, 2024-11-06. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Macerich to report an <strong>earnings per share</strong> (EPS) of $0.40.</p>
<p>The announcement from Macerich is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.03, leading to a 3.12% drop in the share price the following trading session.</p>
<p>Here's a look at Macerich's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.40</td>
<td>0.39</td>
<td></td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.37</td>
<td>0.31</td>
<td>0.56</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Macerich Share Price Analysis</h3>
<p>Shares of Macerich were trading at $18.67 as of November 01. Over the last 52-week period, shares are up 82.68%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Macerich</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Macerich.</p>
<p>Macerich has received a total of 4 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $15.9, the consensus suggests a potential 14.84% downside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Tanger, Phillips Edison and Acadia Realty Trust, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>The consensus outlook from analysts is an Neutral trajectory for Tanger, with an average 1-year price target of $32.5, indicating a potential 74.08% upside.</li>
<li>Phillips Edison is maintaining an Neutral status according to analysts, with an average 1-year price target of $36.67, indicating a potential 96.41% upside.</li>
<li>The consensus among analysts is an Neutral trajectory for Acadia Realty Trust, with an average 1-year price target of $24.33, indicating a potential 30.32% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>In the peer analysis summary, key metrics for Tanger, Phillips Edison and Acadia Realty Trust are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Macerich</td>
<td>Neutral</td>
<td>1.48%</td>
<td>$116.03M</td>
<td>10.52%</td>
</tr>
<tr>
<td>Tanger</td>
<td>Neutral</td>
<td>16.55%</td>
<td>$91.41M</td>
<td>4.44%</td>
</tr>
<tr>
<td>Phillips Edison</td>
<td>Neutral</td>
<td>8.56%</td>
<td>$118.43M</td>
<td>0.51%</td>
</tr>
<tr>
<td>Acadia Realty Trust</td>
<td>Neutral</td>
<td>7.81%</td>
<td>$62.21M</td>
<td>0.44%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Macerich ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>About Macerich</h3>
<p>The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.</p>
<h3>Financial Milestones: Macerich's Journey</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Macerich's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>1.48%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Macerich's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>116.93%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Macerich's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>10.52%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Macerich's ROA excels beyond industry benchmarks, reaching <strong>3.33%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Macerich's debt-to-equity ratio is below the industry average. With a ratio of <b>1.85</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/MAC/earnings"><strong>To track all earnings releases for Macerich visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Macerich's Upcoming Earnings

<p>Ratings for Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $15.9, a high estimate of $19.00, and a low estimate of $14.00. Surpassing the previous average price target of $14.00, the current average has increased by 13.57%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1728673271_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Macerich by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Spector</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Caitlin Burrows</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$14.60</td>
<td>$13.00</td>
</tr>
<tr>
<td>Alexander Goldfarb</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Underweight</td>
<td>$14.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Samir Khanal</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Macerich. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Macerich compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Capture valuable insights into Macerich's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MAC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Macerich analyst ratings.</strong></a></p>
<h2>All You Need to Know About Macerich</h2>
<p>The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.</p>
<h3>Understanding the Numbers: Macerich's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Macerich showcased positive performance, achieving a revenue growth rate of <strong>1.48%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>116.93%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Macerich's ROE excels beyond industry benchmarks, reaching <strong>10.52%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Macerich's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.33%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Macerich's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.85</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Closer Look at 4 Analyst Recommendations For Macerich

<p>B of A Securities  analyst Jeffrey Spector   maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Neutral and raises the price target from $17 to $19.</p>


B of A Securities Maintains Neutral on Macerich, Raises Price Target to $19

<p>As of Sept. 30, 2024, four stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>KE Holdings Inc &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)</strong></h3>
<ul>
<li>On Aug. 12, KE Holdings reported better-than-expected second-quarter financial results and increased its repurchase authorization. The company's stock gained around 37% over the past five days and has a <a href="https://www.benzinga.com/quote/BEKE">52-week high of $20.48</a>.</li>
<li><strong>RSI Value:</strong> 81.63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>BEKE Price Action:</strong> Shares of KE Holdings gained 1.6% to close at $20.00 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Uniti Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>)</strong></h3>
<ul>
<li>On Sept. 27, Uniti Group announced $800 million windstream notes as part of post-merger debt restructuring. The company's stock gained around 34% over the past month and <a href="https://www.benzinga.com/quote/UNIT">has a 52-week high</a> of $6.71.</li>
<li><strong>RSI Value:</strong> 78.03</li>
<li><strong>UNIT Price Action:</strong> Shares of Uniti Group rose 7.6% to close at $5.84 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Macerich Co </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>)</h3>
<ul>
<li>On Sept. 19, Goldman Sachs analyst Caitlin Burrows maintained Macerich with a Sell and raised the price target from $13 to $14.6. The company's stock gained around 18% over the past month and has a <a href="https://www.benzinga.com/quote/MAC">52-week high </a>of $18.04.</li>
<li><strong>RSI Value:</strong> 77.29</li>
<li><strong>MAC Price Action:</strong> Shares of Macerich gained 3.3% to close at $17.95 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>American Healthcare REIT Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>)</h3>
<ul>
<li>On Sept. 24, American Healthcare REIT acquired remaining 24% membership interest in Trilogy REIT Holdings for purchase price of $258 million. The company's stock jumped around 24% over the past month and has a 52-week high is $26.77.</li>
<li><strong>RSI Value:</strong> 80.83</li>
<li><strong>AHR Price Action:</strong> Shares of American Healthcare fell 0.2% to close at $26.12 on Friday. </li>
</ul>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/09/41075978/top-4-materials-stocks-that-may-implode-in-q3">Top 4 Materials Stocks That May Implode In Q3</a></strong></li>
</ul>


<p>Goldman Sachs  analyst Caitlin Burrows   maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sell and raises the price target from $13 to $14.6.</p>


Goldman Sachs Maintains Sell on Macerich, Raises Price Target to $14.6

<p>Piper Sandler  analyst Alexander Goldfarb   maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Underweight and raises the price target from $11 to $14.</p>


Piper Sandler Maintains Underweight on Macerich, Raises Price Target to $14

Macerich upgraded at Mizuho on improved risk/reward

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

GE Vernova initiated, Merck upgraded: Wall Street's top analyst calls

In a report released yesterday, Michael Mueller from J.P. Morgan maintained a Sell rating on Macerich (MAC – Research Report), with a price target ...

Macerich (MAC) Receives a Sell from J.P. Morgan

Piper Sandler analyst Alexander Goldfarb raised the firm's price target on Macerich (MAC) to $17 from $14 and keeps an Underweight rating on the sh...

Macerich price target raised to $17 from $14 at Piper Sandler

Piper Sandler analyst Alexander Goldfarb maintained a Sell rating on Macerich (MAC – Research Report) today and set a price target of $17.00. The c...

Piper Sandler Remains a Sell on Macerich (MAC)

Truist analyst Ki Bin Kim raised the firm's price target on Macerich (MAC) to $23 from $16 and keeps a Hold rating on the shares as part of a broader

Macerich price target raised to $23 from $16 at Truist

Truist Financial analyst Ki Bin Kim maintained a Hold rating on Macerich (MAC – Research Report) today and set a price target of $23.00. The compan...

Truist Financial Keeps Their Hold Rating on Macerich (MAC)

Deutsche Bank analyst Omotayo Okusanya initiated coverage of Macerich (MAC) with a Hold rating and $22 price target The firm has a neutral view on ...

Macerich initiated with a Hold at Deutsche Bank

Scotiabank upgraded Macerich (MAC) to Sector Perform from Underperform with a $22 price target Published first on TheFly – the ultimate source for ...

Government Trades

Macerich Co

top performing MAC trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga